Trial Profile
Metabolism and excretion study of eleclazine in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Eleclazine (Primary)
- Indications Hypertrophic cardiomyopathy; Long QT syndrome; Ventricular arrhythmias
- Focus Adverse reactions; Pharmacokinetics
- 06 Apr 2017 New trial record
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics